TLC therapeutics is a privately-held specialty pharmaceutical company focused on identifying and commercializing innovative pharmaceutical products with unique dosage forms that address unmet needs.
TLC590 is a non-opioid, BioSeizer® sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and ...
TLC therapeutics is a privately-held specialty pharmaceutical company focused on identifying and commercializing innovative pharmaceutical products with unique dosage forms that address unmet needs.
TLC590 is a non-opioid, BioSeizer® sustained release formulation of ropivacaine designed to prolong the retention time of ropivacaine around the injection site as a drug depot, simultaneously extending its therapeutic period and reducing unwanted systemic exposure.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.